Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01105767 · ClinicalTrials.gov registry record · NA
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
A NA study of Staphylococcus Aureus and Staphylococcal Skin Infections, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- NA
- Development phase
- 30,209
- Enrollment target
- 1
- Study location
NCT01105767: Completed NA study of Staphylococcus Aureus and Staphylococcal Skin Infections, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT01105767 is a NA study of Staphylococcus Aureus and Staphylococcal Skin Infections that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 30,209 participants, above the 128-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (23501% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01105767, a NA study of Staphylococcus Aureus and Staphylococcal Skin Infections, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,209 participants
- Enrollment target
- 1
- Study location
Study Summary
This cluster-randomized prospective study will evaluate the effect of hygiene-based intervention strategies on the incidence of overall SSTI and MRSA-associated SSTI among military trainees. The proposed interventions used singly or in combination include standardized training and education, and weekly chlorhexidine showers.
Conditions Studied
Interventions
- DRUG Chlorhexidine gluconate
- OTHER Supplemental training, education and hygiene
Study Locations (1)
Georgia
- Usa Meddac Mach - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,209 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01105767 record still lists
NCT01105767 is an interventional study that assigns participants to a tested intervention. Its 30,209 participants enrollment target places it among the larger protocols in the corpus, above the 128-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (23501% higher).
The record links to 3 conditions, with Staphylococcus Aureus appearing as the primary indexed condition, and to 2 interventions - of which Chlorhexidine gluconate is the first listed.
NCT01105767 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01105767 about?
NCT01105767 is a clinical study titled "Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees". This cluster-randomized prospective study will evaluate the effect of hygiene-based intervention strategies on the incidence of overall SSTI and MRSA-associated SSTI among military trainees. The proposed interventions used singly or in combination include standardized training and education, and wee...
What is the current status of trial NCT01105767?
This trial is currently completed. It is a NA study. The enrollment target is 30,209 participants. The study started on 2010-05. Estimated completion is 2012-01.
What conditions does trial NCT01105767 study?
This clinical trial studies the following conditions: Staphylococcus Aureus, Staphylococcal Skin Infections, MRSA Skin Infections.
What interventions are being tested in trial NCT01105767?
The interventions under investigation include: Chlorhexidine gluconate (DRUG), Supplemental training, education and hygiene (OTHER).
Who is sponsoring clinical trial NCT01105767?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01105767 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcus Aureus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01105767's enrollment target sits among peer trials
30,209 1st of 8 higher than 8 of 8 other Staphylococcus Aureus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Staphylococcus Aureus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
COMPLETED · NA
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
RECRUITING · Phase 1
-
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
RECRUITING · Phase 1
-
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
RECRUITING · Phase 4
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia